Targeting tauopathies for therapeutic translation

被引:0
|
作者
Julio C. Rojas
Adam L. Boxer
机构
[1] Clinical Trials Program,Department of Neurology
[2] Memory and Aging Center,undefined
[3] University of California,undefined
来源
Nature Reviews Neurology | 2016年 / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Tau protein abnormalities are key pathogenic features of Alzheimer disease and other neurodegenerative diseases. In 2015, new studies of the less common tauopathies, including progressive supranuclear palsy, chronic traumatic encephalopathy and frontotemporal lobar degeneration, have identified in vivo biomarkers and mechanisms that initiate tau pathology.
引用
收藏
页码:74 / 76
页数:2
相关论文
共 50 条
  • [41] Targeting translation
    Molloy, Sheilagh
    NATURE REVIEWS MICROBIOLOGY, 2012, 10 (09) : 593 - 593
  • [42] A new tau dephosphorylation-targeting chimera for the treatment of tauopathies
    Su, Jing-fen
    Xiao, Yue
    Wei, Lin-yu
    Lei, Hui-yang
    Sun, Fei
    Wang, Wei-xia
    Li, Shi-hong
    Wang, Xiao-chuan
    Zheng, Jie
    Wang, Jian-zhi
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (11) : 2267 - 2276
  • [43] Immunotherapy for Targeting Tau Pathology in Alzheimer's Disease and Tauopathies
    Rosenmann, Hanna
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (03) : 217 - 228
  • [44] Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies
    Jun Wang
    Wang-Sheng Jin
    Xian-Le Bu
    Fan Zeng
    Zhi-Lin Huang
    Wei-Wei Li
    Lin-Lin Shen
    Zhen-Qian Zhuang
    Yuqiang Fang
    Bin-Lu Sun
    Jie Zhu
    Xiu-Qing Yao
    Gui-Hua Zeng
    Zhi-Fang Dong
    Jin-Tai Yu
    Zhian Hu
    Weihong Song
    Hua-Dong Zhou
    Jian-Xin Jiang
    Yu-Hui Liu
    Yan-Jiang Wang
    Acta Neuropathologica, 2018, 136 : 525 - 536
  • [45] Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies
    Wang, Jun
    Jin, Wang-Sheng
    Bu, Xian-Le
    Zeng, Fan
    Huang, Zhi-Lin
    Li, Wei-Wei
    Shen, Lin-Lin
    Zhuang, Zhen-Qian
    Fang, Yuqiang
    Sun, Bin-Lu
    Zhu, Jie
    Yao, Xiu-Qing
    Zeng, Gui-Hua
    Dong, Zhi-Fang
    Yu, Jin-Tai
    Hu, Zhian
    Song, Weihong
    Zhou, Hua-Dong
    Jiang, Jian-Xin
    Liu, Yu-Hui
    Wang, Yan-Jiang
    ACTA NEUROPATHOLOGICA, 2018, 136 (04) : 525 - 536
  • [46] Nontoxic singlet oxygen generator as a therapeutic candidate for treating tauopathies
    Mohideen, Sahabudeen Sheik
    Yamasaki, Yasutoyo
    Omata, Yasuhiro
    Tsuda, Leo
    Yoshiike, Yuji
    SCIENTIFIC REPORTS, 2015, 5
  • [47] Heparan Sulfate as a Therapeutic Target in Tauopathies: Insights From Zebrafish
    Naini, Seyedeh Maryam Alavi
    Soussi-Yanicostas, Nadia
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2018, 6
  • [48] Nontoxic singlet oxygen generator as a therapeutic candidate for treating tauopathies
    Sahabudeen Sheik Mohideen
    Yasutoyo Yamasaki
    Yasuhiro Omata
    Leo Tsuda
    Yuji Yoshiike
    Scientific Reports, 5
  • [49] Reevaluating tau reduction as a therapeutic approach for tauopathies: Insights and perspectives
    Sun, Xiaohuan
    Ogbolu, Victor C.
    Baas, Peter W.
    Qiang, Liang
    CYTOSKELETON, 2024, 81 (01) : 57 - 62
  • [50] A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies
    Zheng, Jie
    Tian, Na
    Liu, Fei
    Zhang, Yidian
    Su, Jingfen
    Gao, Yang
    Deng, Mingmin
    Wei, Linyu
    Ye, Jingwang
    Li, Honglian
    Wang, Jian-Zhi
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)